Metraipolis › archive › dc_c346ff181e60
Implications of the 2025 AHA/ACC high blood pressure guidelines on the initiation and intensification of blood pressure-lowering medications among US adults — Europe PMC PMID:41767443
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41767443
- DOI
- 10.1016/j.ajpc.2025.101400
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T17:32:26.259Z
- SHA-256 of the archived text
e04ff734c9f7838dca3bf744dfd2075d3888613f70f66da262104a7b4bbdf2de- Stable URL of this page
https://metraipolis.com/documento/dc_c346ff181e60
How to cite
Implications of the 2025 AHA/ACC high blood pressure guidelines on the initiation and intensification of blood pressure-lowering medications among US adults — Europe PMC PMID:41767443 — Europe PMC (en), https://europepmc.org/article/MED/41767443 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c346ff181e60 (Metraipolis archive dc_c346ff181e60, sha256 e04ff734c9f7838dca3bf744dfd2075d3888613f70f66da262104a7b4bbdf2de)
BibTeX
@misc{dcc346ff181e60,
title = {Implications of the 2025 AHA/ACC high blood pressure guidelines on the initiation and intensification of blood pressure-lowering medications among US adults — Europe PMC PMID:41767443},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41767443},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c346ff181e60; sha256 e04ff734c9f7838dca3bf744dfd2075d3888613f70f66da262104a7b4bbdf2de},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41767443. Agents can read the archived copy with the MCP tool read_document.